Web Date: March 8, 2006
Drug Eases Alzheimer's In Mice
The experimental drug AF267B improves memory and reduces brain pathology in a transgenic mouse model of Alzheimer???s disease, according to University of California, Irvine, neurobiologist Frank M. LaFerla and colleagues (Neuron 2006, 49, 671).
As the disease develops in humans and in the team???s transgenic mice, amyloid plaques and neurofibrillary tangles of tau protein accumulate in the brain; levels of the neurotransmitter acetylcholine also decline. AF267B mimics the missing neurotransmitter. When the drug binds . . .
You Do Not Have Access to C&EN Protected Content.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society